Keywords: japan, nda, filed, nartograstim, kyowa, hakko, new

JAPAN: NDA FILED FOR NARTOGRASTIM

Article | 12 October 1992

Japan's Kyowa Hakko has filed a New Drug Application for nartograstim (recombinant mutein granulocyte colony stimulating factor) with the Japanese ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Kyowa Hakko

Go to company listing

Related Drugs

Antihemophilic Factor

Recombinant

Coagulation Factor VIIa

Go to drug listing